IGFBP6通过激活ATF4位和减少ER逆转移位子表达来调节蛋白质稳定
O E Kolodeeva1, O E Kolodeeva1, I D Antipenko1
1Faculty of Biology and Biotechnology, National Research University Higher School of Economics, Moscow, Russia.
Doklady. Biochemistry and biophysics
|October 31, 2024
概括
乳腺癌细胞中IGFBP6蛋白减少会增加转移. 这会影响蛋白质合成调节和细胞应激反应,影响蛋白质稳定和与ER相关的降解途径.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 细胞生物学 细胞生物学
背景情况:
- 减少胰岛素类生长因子结合蛋白6 (IGFBP6) 表达与增加乳腺癌 (BC) 转移潜力相关.
- 瘤细胞表现出较高的蛋白质合成,需要进行补偿性蛋白质稳定调整.
- 核糖体失活蛋白 (RIPs) 和素一样,是通过向核糖体来研究蛋白质稳定性的工具.
研究的目的:
- 调查IGFBP6基因淘汰对MDA-MB-231乳腺癌细胞系中蛋白质稳定性的影响.
- 阐明IGFBP6影响BC蛋白质合成和细胞应激反应的机制.
主要方法:
- 在MDA-MB-231 BC细胞系中利用IGFBP6基因淘汰.
- 通过素毒素评估核糖体修饰效率.
- 分析了参与ER相关降解 (ERAD) 和展开蛋白质反应 (UPR) 途径的关键蛋白质的表达水平.
主要成果:
- 被IGFBP6淘汰的MDA-MB-231细胞显示了由素减少的核糖体修饰.
- 这种减少的修饰可能与素催化子单元从ER到细胞质的运输受损有关.
- 观察到HRD1/Derlin亚单元 (ERAD成分) 的表达减少和ATF4向基因 (UPR通路) 的表达增加.
结论:
- 乳腺癌细胞中的IGFBP6缺乏会改变蛋白质稳定和细胞应激反应.
- 这些变化包括核糖体功能受损,ERAD效率降低以及UPR通路的激活.
- 了解这些机制可能为乳腺癌转移提供新的治疗点.
相关概念视频
The Unfolded Protein Response
4.4K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
Regulation of Expression at Multiple Steps
873
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
873


